Analyst Expect Big Moves From Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 399.15M common shares owned by the public and among those 307.84M shares have been available to trade. The company’s stock has a 5-day price change of 5.31% and -56.70% over the past three months. RXRX shares are trading -32.54% year to date (YTD), with the 12-month market performance down to -54.63% lower. […]
Analyst Expect Big Moves From Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 399.15M common shares owned by the public and among those 307.84M shares have been available to trade. The company’s stock has a 5-day price change of -24.04% and -42.19% over the past three months. RXRX shares are trading -35.95% year to date (YTD), with the 12-month market performance down to -50.74% lower. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Is Getting Increasingly Hard To Ignore
Currently, there are 389.55M common shares owned by the public and among those 304.31M shares have been available to trade. The company’s stock has a 5-day price change of -0.52% and -21.27% over the past three months. RXRX shares are trading -15.68% year to date (YTD), with the 12-month market performance down to -27.11% lower. […]
Recursion Pharmaceuticals Inc (RXRX) Testing Investors’ Patience Right Now
Currently, there are 389.55M common shares owned by the public and among those 305.89M shares have been available to trade. The company’s stock has a 5-day price change of 4.18% and -21.83% over the past three months. RXRX shares are trading -15.24% year to date (YTD), with the 12-month market performance down to -25.58% lower. […]
Analyst Expect Big Moves From Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 389.55M common shares owned by the public and among those 305.89M shares have been available to trade. The company’s stock has a 5-day price change of -6.08% and -17.15% over the past three months. RXRX shares are trading -19.97% year to date (YTD), with the 12-month market performance down to -27.58% lower. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Has Another Chance To Impress You
Currently, there are 389.55M common shares owned by the public and among those 305.89M shares have been available to trade. The company’s stock has a 5-day price change of 35.85% and -16.28% over the past three months. RXRX shares are trading -14.79% year to date (YTD), with the 12-month market performance down to -32.87% lower. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): Stock That Needs Special Handling
Currently, there are 389.55M common shares owned by the public and among those 305.89M shares have been available to trade. The company’s stock has a 5-day price change of -20.60% and -46.15% over the past three months. RXRX shares are trading -37.87% year to date (YTD), with the 12-month market performance down to -51.89% lower. […]
Recursion Pharmaceuticals Inc (RXRX) Testing Investors’ Patience Right Now
Currently, there are 389.55M common shares owned by the public and among those 305.72M shares have been available to trade. The company’s stock has a 5-day price change of -13.02% and -19.75% over the past three months. RXRX shares are trading -14.05% year to date (YTD), with the 12-month market performance down to -43.70% lower. […]
Recursion Pharmaceuticals Inc (RXRX) Testing Investors’ Patience Right Now
Currently, there are 389.55M common shares owned by the public and among those 305.72M shares have been available to trade. The company’s stock has a 5-day price change of -0.73% and 9.25% over the past three months. RXRX shares are trading 0.44% year to date (YTD), with the 12-month market performance down to -38.66% lower. […]
Look At Analyst Expectations For A Better Read On Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 389.55M common shares owned by the public and among those 305.79M shares have been available to trade. The company’s stock has a 5-day price change of -3.64% and -14.88% over the past three months. RXRX shares are trading -6.07% year to date (YTD), with the 12-month market performance down to -39.75% lower. […]
